Thus, a decline of NAMPT in aging or age-associated Alzheimer’s disease (AD) brain may decrease NADH levels that in turn could cause an oxidized redox shift, lower GSH levels and promote neurodegeneration (Brewer, 2010; Ghosh et al., 2012). This evidence concerns the gene NAMPT and Alzheimer disease.